3
Clinical Trials associated with Recombinant erythropoietin long-acting(Shandong Kexing Bioproducts Co., Ltd.)重组人促红素注射液(CHO 细胞)治疗非骨髓恶性肿瘤化疗引起贫血的随机、开放、阳性药平行对照、多中心临床试验
[Translation] A randomized, open, positive drug parallel controlled, multicenter clinical trial of recombinant human erythropoietin injection (CHO cells) in the treatment of chemotherapy-induced anemia in patients with non-myeloid malignancies
以重组人促红素注射液(益比奥)为对照,评价重组人促红素注射液(依普定)治疗非骨髓恶性肿瘤化疗引起的贫血的有效性和安全性。
[Translation] To evaluate the efficacy and safety of recombinant human erythropoietin injection (EPIAO) in the treatment of anemia induced by chemotherapy for non-myeloid malignancies, using recombinant human erythropoietin injection (EPIAO) as a control.
重组人促红素注射液(CHO细胞)治疗非骨髓恶性肿瘤化疗引起的贫血 ──随机对照、多中心临床试验
[Translation] Recombinant human erythropoietin injection (CHO cells) for the treatment of chemotherapy-induced anemia in patients with non-myeloid malignancies: a randomized, controlled, multicenter clinical trial
以重组人促红素注射液(益比奥)为对照,评价重组人促红素注射液(依普定)治疗非骨髓恶性肿瘤化疗引起的贫血的有效性和安全性。
[Translation] To evaluate the efficacy and safety of recombinant human erythropoietin injection (EPIAO) in the treatment of anemia caused by chemotherapy for non-myeloid malignancies, using recombinant human erythropoietin injection (EPIAO) as a control.
重组人促红素注射液(CHO细胞)治疗非恶性肿瘤化疗引起的贫血--随机、单盲、阳性药平行对照、多中心临床试验
[Translation] Recombinant human erythropoietin injection (CHO cells) for the treatment of anemia caused by chemotherapy for non-malignant tumors: a randomized, single-blind, positive drug parallel controlled, multicenter clinical trial
评价重组人促红素(依普定)治疗非骨髓恶性肿瘤化疗引起的贫血的有效性和安全性。
[Translation] To evaluate the efficacy and safety of recombinant human erythropoietin (Epodin) in the treatment of chemotherapy-induced anemia in patients with non-myeloid malignancies.
100 Clinical Results associated with Recombinant erythropoietin long-acting(Shandong Kexing Bioproducts Co., Ltd.)
100 Translational Medicine associated with Recombinant erythropoietin long-acting(Shandong Kexing Bioproducts Co., Ltd.)
100 Patents (Medical) associated with Recombinant erythropoietin long-acting(Shandong Kexing Bioproducts Co., Ltd.)
100 Deals associated with Recombinant erythropoietin long-acting(Shandong Kexing Bioproducts Co., Ltd.)